These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33231340)

  • 1. Crosstalk between head and neck cancer cells and lymphatic endothelial cells promotes tumor metastasis via CXCL5-CXCR2 signaling.
    Lee BS; Jang JY; Seo C; Kim CH
    FASEB J; 2021 Jan; 35(1):e21181. PubMed ID: 33231340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma.
    Roy S; Kumaravel S; Banerjee P; White TK; O'Brien A; Seelig C; Chauhan R; Ekser B; Bayless KJ; Alpini G; Glaser SS; Chakraborty S
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
    Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J
    Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis.
    Zhou Z; Xia G; Xiang Z; Liu M; Wei Z; Yan J; Chen W; Zhu J; Awasthi N; Sun X; Fung KM; He Y; Li M; Zhang C
    Clin Cancer Res; 2019 Jun; 25(11):3317-3328. PubMed ID: 30796034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways.
    Cui D; Zhao Y; Xu J
    Cancer Biol Ther; 2019; 20(5):608-616. PubMed ID: 30404567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
    Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
    Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.
    Cui D; Zhao Y; Xu J
    Biochimie; 2018 May; 148():1-11. PubMed ID: 29471001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis.
    Romero-Moreno R; Curtis KJ; Coughlin TR; Miranda-Vergara MC; Dutta S; Natarajan A; Facchine BA; Jackson KM; Nystrom L; Li J; Kaliney W; Niebur GL; Littlepage LE
    Nat Commun; 2019 Sep; 10(1):4404. PubMed ID: 31562303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
    Gao Y; Guan Z; Chen J; Xie H; Yang Z; Fan J; Wang X; Li L
    Int J Oncol; 2015 Aug; 47(2):690-700. PubMed ID: 26058729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
    Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
    Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of CXCL5 inhibits squamous carcinogenesis.
    Miyazaki H; Patel V; Wang H; Edmunds RK; Gutkind JS; Yeudall WA
    Cancer Res; 2006 Apr; 66(8):4279-84. PubMed ID: 16618752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteocytes support bone metastasis of melanoma cells by CXCL5.
    Jia Y; Zhang F; Meng X; Andreev D; Lyu P; Zhang W; Lai C; Schett G; Bozec A
    Cancer Lett; 2024 May; 590():216866. PubMed ID: 38589005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
    Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
    Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
    Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
    Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.
    Kumaravel S; Singh S; Roy S; Venkatasamy L; White TK; Sinha S; Glaser SS; Safe SH; Chakraborty S
    Am J Pathol; 2020 Apr; 190(4):900-915. PubMed ID: 32035061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.
    Li A; King J; Moro A; Sugi MD; Dawson DW; Kaplan J; Li G; Lu X; Strieter RM; Burdick M; Go VL; Reber HA; Eibl G; Hines OJ
    Am J Pathol; 2011 Mar; 178(3):1340-9. PubMed ID: 21356384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown.
    Haarmann A; Schuhmann MK; Silwedel C; Monoranu CM; Stoll G; Buttmann M
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.
    Ando Y; Ohuchida K; Otsubo Y; Kibe S; Takesue S; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Oda Y; Nakamura M
    PLoS One; 2020; 15(1):e0228015. PubMed ID: 31999765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.
    Wang G; Lu X; Dey P; Deng P; Wu CC; Jiang S; Fang Z; Zhao K; Konaparthi R; Hua S; Zhang J; Li-Ning-Tapia EM; Kapoor A; Wu CJ; Patel NB; Guo Z; Ramamoorthy V; Tieu TN; Heffernan T; Zhao D; Shang X; Khadka S; Hou P; Hu B; Jin EJ; Yao W; Pan X; Ding Z; Shi Y; Li L; Chang Q; Troncoso P; Logothetis CJ; McArthur MJ; Chin L; Wang YA; DePinho RA
    Cancer Discov; 2016 Jan; 6(1):80-95. PubMed ID: 26701088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF-C contributes to head and neck squamous cell carcinoma growth and motility.
    Benke EM; Ji Y; Patel V; Wang H; Miyazaki H; Yeudall WA
    Oral Oncol; 2010 Apr; 46(4):e19-24. PubMed ID: 20227330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.